{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:04:11Z","timestamp":1789772651766,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1816,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jcf.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T13:06:52Z","timestamp":1211461612000},"page":"433-436","source":"Crossref","is-referenced-by-count":27,"title":["Improvement in clinical markers in CF patients using a reduced glutathione regimen: An uncontrolled, observational study"],"prefix":"10.1016","volume":"7","author":[{"given":"Alfredo","family":"Visca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark T.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie M.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib1","doi-asserted-by":"crossref","first-page":"C323","DOI":"10.1152\/ajpcell.1998.275.1.C323","article-title":"Glutathione permeability of CFTR","volume":"44","author":"Linsdell","year":"1998","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"L113","DOI":"10.1152\/ajplung.1999.277.1.L113","article-title":"Abnormal glutathione transport in cystic fibrosis airway epithelia","volume":"277","author":"Gao","year":"1999","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib3","doi-asserted-by":"crossref","first-page":"L31","DOI":"10.1152\/ajplung.2001.281.1.L31","article-title":"Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice","volume":"281","author":"Velsor","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.jcf.2008.03.006_bib4","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/IAI.72.4.2045-2051.2004","article-title":"Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection","volume":"72","author":"Day","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcf.2008.03.006_bib5","first-page":"189","article-title":"Characterization of glutathione permeability through the CFTR channel pore","volume":"24","author":"Kogan","year":"2002","journal-title":"Ped Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2008.03.006_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/emboj\/cdg194","article-title":"CFTR directly mediates nucleotide-regulated glutathione flux","volume":"22","author":"Kogan","year":"2003","journal-title":"EMBO"},{"key":"10.1016\/j.jcf.2008.03.006_bib7","first-page":"16","article-title":"A role for CFTR in the elevation of glutathione in the lung by oral glutathione administrations","author":"Kariya","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.jcf.2008.03.006_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1165\/rcmb.2005-0473OC","article-title":"Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice","volume":"35","author":"Velsor","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1378\/chest.127.1.12","article-title":"Glutathione: a radical treatment for cystic fibrosis lung disease?","volume":"127","author":"Day","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jcf.2008.03.006_bib10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/IAI.72.4.2045-2051.2004","article-title":"Role for cystic fibrosis transmembrane conductance regulator in a glutathione response to bronchopulmonary pseudomonas infection","volume":"72","author":"Day","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1378\/chest.116.1.201","article-title":"Lymphocyte glutathione levels in children with cystic fibrosis","volume":"116","author":"Lands","year":"1999","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2006.09.022","article-title":"Antioxidants in cystic fibrosis","volume":"42","author":"Cantin","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.jcf.2008.03.006_bib13","doi-asserted-by":"crossref","first-page":"C218","DOI":"10.1152\/ajpcell.00605.2005","article-title":"Innate immune response in CF airway epithelia: hyperinflammatory?","volume":"291","author":"Machen","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"14","key":"10.1016\/j.jcf.2008.03.006_bib14","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M513231200","article-title":"Mechanisms of cystic fibrosis transmembrane conductance regulator activation by S-nitrosoglutathione","volume":"281","author":"Chen","year":"2006","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jcf.2008.03.006_bib15","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1152\/jappl.1993.75.6.2419","article-title":"Systemic deficiency of glutathione in cystic fibrosis","volume":"75","author":"Roum","year":"1993","journal-title":"J Appl Physiol"},{"issue":"12","key":"10.1016\/j.jcf.2008.03.006_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0891-5849(01)00530-5","article-title":"Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation","volume":"30","author":"Hudson","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1152\/jappl.1999.87.1.438","article-title":"Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis","volume":"87","author":"Roum","year":"1999","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1016\/j.jcf.2008.03.006_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1378\/chest.127.1.308","article-title":"A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis","volume":"127","author":"Bishop","year":"2005","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.jcf.2008.03.006_bib19","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione pro-drug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"PNAS USA"},{"issue":"4","key":"10.1016\/j.jcf.2008.03.006_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.freeradbiomed.2005.03.032","article-title":"Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs","volume":"39","author":"Hartl","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.jcf.2008.03.006_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1569-1993(03)00097-3","article-title":"Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein","volume":"2","author":"Grey","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2008.03.006_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200308-1104OC","article-title":"Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis","volume":"169","author":"Griese","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcf.2008.03.006_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/ajrccm.165.7.2105032","article-title":"Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis","volume":"165","author":"Snyder","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2008.03.006_bib24","unstructured":"Letter to Dr. Clark Bishop from the U.S. Food and Drug Administration, 17 July 2006, signed by Mary H. Parks, M.D., ODE II, CDER, in recipient's possession."},{"issue":"3 Pt 1","key":"10.1016\/j.jcf.2008.03.006_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.112.3.588","article-title":"Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis","volume":"112","author":"Peterson","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jcf.2008.03.006_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/mpd.2000.107891","article-title":"Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry","volume":"137","author":"Zemel","year":"2000","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.jcf.2008.03.006_bib27","first-page":"350","article-title":"Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction","volume":"11","author":"Thomson","year":"1995","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.jcf.2008.03.006_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thorax.57.7.596","article-title":"Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project","volume":"57","author":"Steinkamp","year":"2002","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.jcf.2008.03.006_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1067\/mpd.2003.152","article-title":"Investigators and coordinators of the epidemiologic study of cystic fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis","volume":"142","author":"Konstan","year":"2003","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2008.03.006_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/adc.82.5.394","article-title":"Intestinal inflammation in cystic fibrosis","volume":"82","author":"Smyth","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2008.03.006_bib31","series-title":"Investigator's brochure on oral reduced glutathione (GSH)","year":"2007"},{"key":"10.1016\/j.jcf.2008.03.006_bib32","unstructured":"Griese, Matthias, \u201cEfficacy and safety of inhaled glutathione in cystic fibrosis patients,\u201d http:\/\/clinicaltrials.gov\/show\/NCT00506688"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199308000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199308000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T15:43:19Z","timestamp":1557589399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199308000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1569199308000337"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2008.03.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}